Blogs Ruby CY Lin, Jon Iredell Brendan Taylor 14/2/24 Ruby CY Lin, Jon Iredell Brendan Taylor 14/2/24 Phage Therapy: A promising solution in the battle against superbugs Phage therapy Read More Ruby CY Lin, Ameneh Khatami, Anton Peleg, Stephen Stick, Steven Tong, Morgyn Warner, Stephanie Lynch, Jon Iredell Brendan Taylor 10/3/23 Ruby CY Lin, Ameneh Khatami, Anton Peleg, Stephen Stick, Steven Tong, Morgyn Warner, Stephanie Lynch, Jon Iredell Brendan Taylor 10/3/23 The antimicrobial potential of bacteriophages – UK Parliament Inquiry 2023 Phage, Business Models, Sustainability Read More Jon Iredell, Jessica Sacher Brendan Taylor 20/1/23 Jon Iredell, Jessica Sacher Brendan Taylor 20/1/23 Investing in the future of phage therapy Phage, Business Models, Sustainability Read More
Ruby CY Lin, Jon Iredell Brendan Taylor 14/2/24 Ruby CY Lin, Jon Iredell Brendan Taylor 14/2/24 Phage Therapy: A promising solution in the battle against superbugs Phage therapy Read More
Ruby CY Lin, Ameneh Khatami, Anton Peleg, Stephen Stick, Steven Tong, Morgyn Warner, Stephanie Lynch, Jon Iredell Brendan Taylor 10/3/23 Ruby CY Lin, Ameneh Khatami, Anton Peleg, Stephen Stick, Steven Tong, Morgyn Warner, Stephanie Lynch, Jon Iredell Brendan Taylor 10/3/23 The antimicrobial potential of bacteriophages – UK Parliament Inquiry 2023 Phage, Business Models, Sustainability Read More
Jon Iredell, Jessica Sacher Brendan Taylor 20/1/23 Jon Iredell, Jessica Sacher Brendan Taylor 20/1/23 Investing in the future of phage therapy Phage, Business Models, Sustainability Read More